Authors/Disclosures
|
Indranil Sen-Gupta, MD
|
Dr. Sen-Gupta has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global Advisors. |
|
Stephan Schuele, MD, FAAN
(Northwestern Memorial Hospital)
|
Dr. Schuele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Monteris. Dr. Schuele has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurelis. Dr. Schuele has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Science. Dr. Schuele has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jazz. Dr. Schuele has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neurophysiology. Dr. Schuele has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Thomas Needham. Dr. Schuele has received research support from National Institute of Health. |
|
Michael P. Macken, MD, MRCPI
(Northwestern Medical Faculty Foundation)
|
Dr. Macken has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharma. Dr. Macken has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK LifeSciences. Dr. Macken has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for LivaNova. Dr. Macken has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Hall Prangle Shonfeld. The institution of Dr. Macken has received research support from LivaNova. |
|
Robert P. Rubens, MD, MBA, FAAN, FAAN
(NeuroDevMA Consulting, Inc.)
|
Dr. Rubens has received personal compensation for serving as an employee of Takeda Pharmaceuticals. Dr. Rubens has received stock or an ownership interest from Takeda Pharmaceuticals. |
|
Elizabeth Gerard, MD
(Northwestern University)
|
Dr. Gerard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon. The institution of Dr. Gerard has received research support from NIH/NINDS. The institution of Dr. Gerard has received research support from Xenon Pharmaceuticals. The institution of an immediate family member of Dr. Gerard has received research support from NIH. The institution of Dr. Gerard has received research support from Eisai, Inc. (via Stanford University). Dr. Gerard has received publishing royalties from a publication relating to health care. |
|
Rui Chang, MD
|
No disclosure on file |